<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">JAMA Health Forum</journal-id><journal-id journal-id-type="iso-abbrev">JAMA Health Forum</journal-id><journal-title-group><journal-title>JAMA Health Forum</journal-title></journal-title-group><issn pub-type="epub">2689-0186</issn><publisher><publisher-name>American Medical Association</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39888639</article-id><article-id pub-id-type="pmc">PMC11786227</article-id>
<article-id pub-id-type="doi">10.1001/jamahealthforum.2024.5279</article-id><article-id pub-id-type="publisher-id">ald240040</article-id><article-categories><subj-group subj-group-type="category" specific-use="electronic"><subject>Research</subject></subj-group><subj-group subj-group-type="domain" specific-use="print"><subject>Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Letter</subject></subj-group><subj-group subj-group-type="online-only"><subject>Online Only</subject></subj-group><subj-group subj-group-type="allowCommenting"><subject>Comments</subject></subj-group></article-categories><title-group><article-title>Persistence of Social Norms Feedback on Postsurgery Opioid Prescribing Behavior</article-title><subtitle>Secondary Analysis of a Randomized Clinical Trial</subtitle><alt-title alt-title-type="headline">Persistence of Social Norms Feedback on Postsurgery Opioid Prescribing Behavior</alt-title><alt-title alt-title-type="running-head">Persistence of Social Norms Feedback on Postsurgery Opioid Prescribing Behavior</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Zanocco</surname><given-names>Kyle A.</given-names></name><degrees>MD</degrees><xref rid="ald240040aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Wagner</surname><given-names>Zachary</given-names></name><degrees>PhD</degrees><xref rid="ald240040aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Mariano</surname><given-names>Louis T.</given-names></name><degrees>PhD</degrees><xref rid="ald240040aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Kirkegaard</surname><given-names>Allison</given-names></name><degrees>MTS</degrees><xref rid="ald240040aff4" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Yan</surname><given-names>Xiaowei</given-names></name><degrees>PhD</degrees><xref rid="ald240040aff5" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Fox</surname><given-names>Craig R.</given-names></name><degrees>PhD</degrees><xref rid="ald240040aff6" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Goldstein</surname><given-names>Noah J.</given-names></name><degrees>PhD</degrees><xref rid="ald240040aff6" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Brummett</surname><given-names>Chad M.</given-names></name><degrees>MD</degrees><xref rid="ald240040aff7" ref-type="aff">
<sup>7</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Watkins</surname><given-names>Katherine E.</given-names></name><degrees>MD</degrees><degrees>MSHS</degrees><xref rid="ald240040aff4" ref-type="aff">
<sup>4</sup>
</xref></contrib></contrib-group><aff id="ald240040aff1"><label>1</label>Section of Endocrine Surgery, Division of General Surgery, Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles</aff><aff id="ald240040aff2"><label>2</label>Center for Economic and Social Research, University of Southern California, Los Angeles</aff><aff id="ald240040aff3"><label>3</label>RAND Corporation, Arlington, Virginia</aff><aff id="ald240040aff4"><label>4</label>RAND Corporation, Santa Monica, California</aff><aff id="ald240040aff5"><label>5</label>Palo Alto Medical Foundation, Palo Alto, California</aff><aff id="ald240040aff6"><label>6</label>Anderson School of Management, Department of Psychology, College of Letters and Sciences, and David Geffen School of Medicine, University of California, Los Angeles</aff><aff id="ald240040aff7"><label>7</label>Division of Pain Medicine, Department of Anesthesiology, University of Michigan Medical School, Ann Arbor</aff><author-notes><title>Article Information</title><p><bold>Accepted for Publication:</bold> November 27, 2024.</p><p content-type="published-online"><bold>Published:</bold> January 31, 2025. doi:<uri content-type="doi">10.1001/jamahealthforum.2024.5279</uri></p><p content-type="open-access-note"><bold>Open Access:</bold> This is an open access article distributed under the terms of the <ext-link xlink:href="https://jamanetwork.com/pages/cc-by-license-permissions" ext-link-type="uri">CC-BY License</ext-link>. &#x000a9; 2025 Zanocco KA et al. <italic>JAMA Health Forum</italic>.</p><corresp id="ald240040cor1"><bold>Corresponding Author:</bold> Kyle A. Zanocco, MD, Section of Endocrine Surgery, Division of General Surgery, Department of Surgery, David Geffen School of Medicine at UCLA, 10833 Le Conte Ave, 72-222 CHS, Los Angeles, CA 90095 (<email xlink:href="kzanocco@mednet.ucla.edu">kzanocco@mednet.ucla.edu</email>).</corresp><p content-type="author-contributions"><bold>Author Contributions:</bold> Dr Wagner had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.</p><p><italic>Concept and design:</italic> All authors.</p><p><italic>Acquisition, analysis, or interpretation of data:</italic> Zanocco, Wagner, Mariano, Kirkegaard, Fox.</p><p><italic>Drafting of the manuscript:</italic> Zanocco, Wagner, Mariano, Yan, Watkins.</p><p><italic>Critical review of the manuscript for important intellectual content:</italic> Zanocco, Wagner, Mariano, Kirkegaard, Fox, Goldstein, Brummett.</p><p><italic>Statistical analysis:</italic> Wagner, Mariano, Yan.</p><p><italic>Obtained funding:</italic> Fox, Goldstein, Watkins.</p><p><italic>Administrative, technical, or material support:</italic> Kirkegaard, Brummett.</p><p><italic>Supervision:</italic> Wagner, Yan.</p><p content-type="COI-statement"><bold>Conflict of Interest Disclosures:</bold> Dr Brummett reported receiving personal fees from Vertex Pharmaceuticals, Merck, and from providing expert testimony outside the submitted work. No other disclosures were reported.</p><p content-type="funding-statement"><bold>Funding/Support:</bold> This study was funded by grant 1R01DA046226 from the National Institute on Drug Abuse (Dr Watkins).</p><p><bold>Role of the Funder/Sponsor:</bold> The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</p><p content-type="data-sharing-statement"><bold>Data Sharing Statement:</bold> See <xref rid="note-ALD240040-1-s" ref-type="supplementary-material">Supplement 3</xref>.</p></author-notes><pub-date pub-type="epub" iso-8601-date="2025-01-31T10:00"><day>31</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>1</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>31</day><month>1</month><year>2025</year></pub-date><!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.--><volume>6</volume><issue>1</issue><elocation-id>e245279</elocation-id><history><date date-type="received"><day>14</day><month>9</month><year>2024</year></date><date date-type="accepted"><day>27</day><month>11</month><year>2024</year></date></history><permissions><copyright-statement>Copyright 2025 Zanocco KA et al. <italic>JAMA Health Forum</italic>.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the CC-BY License.</license-p></license></permissions><self-uri content-type="pdf-version" xlink:href="jamahealthforum-e245279.pdf">jamahealthforum-e245279.pdf</self-uri><self-uri content-type="silverchair" xlink:href="https://jamanetwork.com/channels/health-forum/fullarticle/10.1001/jamahealthforum.2024.5279"/><abstract abstract-type="teaser" specific-use="electronic"><p>This secondary analysis of a randomized clinical trial evaluates the persistence of prescribing guideline-recommended postoperative opioids 1 year after intervention cessation.</p></abstract></article-meta></front><body><sec id="H1-1-ALD240040"><title>Introduction</title><p>Prescribing excess opioids to surgical patients increases the risk of chronic opioid use and diversion of unused opioids.<sup><xref rid="ald240040r1" ref-type="bibr">1</xref>,<xref rid="ald240040r2" ref-type="bibr">2</xref></sup> In a recent cluster randomized clinical trial (RCT), social norms&#x02013;based feedback to surgeons prescribing postoperative opioids above guideline-recommended quantities showed significantly reduced guideline-discordant prescribing behavior during the intervention period.<sup><xref rid="ald240040r3" ref-type="bibr">3</xref></sup> This study describes the persistence of effects 1 year after stopping the interventions.</p></sec><sec id="H1-2-ALD240040"><title>Methods</title><p>This cluster RCT was conducted among general, orthopedic, and obstetric and gynecologic surgical specialties at 19 hospitals in California between October 19, 2021, and October 18, 2022.<sup><xref rid="ald240040r3" ref-type="bibr">3</xref></sup> This secondary analysis and waiver of participant informed consent were approved by the Sutter Health Institutional Review Board. The trial protocol is provided in <xref rid="note-ALD240040-1-s" ref-type="supplementary-material">Supplement 1</xref>. This study followed <ext-link xlink:href="https://www.equator-network.org/reporting-guidelines/consort/" ext-link-type="uri">CONSORT</ext-link> reporting guidelines.</p><p>Surgeons were randomized to receive feedback on opioid prescribing relative to institutionally endorsed guidelines (guidelines intervention) or peer surgeons (peer comparison intervention) or to a control group (no intervention). Surgeons in the intervention groups received monthly email feedback after operating on patients discharged with opioid prescriptions exceeding procedure-specific guidelines. The primary outcome was the share of discharge opioid prescriptions for which total quantities exceeded guideline recommendations. As a prespecified secondary objective, prescribing data were collected from electronic health records for 1 year following intervention discontinuation. We provided study results to surgeons after the 1-year follow-up concluded.</p><p>We estimated the persistent intervention effects at the discharged patient level using ordinary least squares regression for the same primary outcome. This procedure deviates from our original primary approach, as explained in the eMethods in <xref rid="note-ALD240040-1-s" ref-type="supplementary-material">Supplement 2</xref>. We estimated mean effects across the entire postintervention period and separately for each postintervention month. We controlled for preintervention outcome levels and clustered standard errors by randomization cluster. <italic>P</italic>&#x02009;&#x0003c;&#x02009;.05 was considered significant. Statistical analysis was performed using Stata/SE, version 18 (StataCorp LLC).</p></sec><sec id="H1-3-ALD240040"><title>Results</title><p>In the preintervention period, among 778 surgeons randomized (245 in the control arm, 257 in the peer comparison arm, and 267 in the guidelines arm) (<xref rid="ald240040f1" ref-type="fig">Figure 1</xref>), the share of discharges with an opioid prescription exceeding guideline recommendations was approximately 35% to 40% in each arm (<xref rid="ald240040f2" ref-type="fig">Figure 2</xref>). During the intervention, the mean (SD) share was 25.5% (43.5%) in the guidelines arm, 27.5% (44.7%) for peer comparison, and 36.8% (48.2%) in the control arm. During the postintervention period, 34&#x02009;024 patients were discharged after procedures performed by 547 surgeons (85% of 640 analyzed during the intervention period) (<xref rid="ald240040f1" ref-type="fig">Figure 1</xref>).</p><fig position="float" id="ald240040f1" fig-type="figure"><label>Figure 1. </label><caption><title>Flow Diagram</title></caption><graphic xlink:href="jamahealthforum-e245279-g001" position="float"/></fig><fig position="float" id="ald240040f2" fig-type="figure"><label>Figure 2. </label><caption><title>Prescribing Above Guideline Quantities Over Time by Intervention</title><p>The intervention effects in each month, after controlling for baseline prescribing and with standard errors clustered by randomization cluster, are absolute percentage point differences. The error bars indicate 95% CIs.</p></caption><graphic xlink:href="jamahealthforum-e245279-g002" position="float"/></fig><p>Control surgeons prescribed above guidelines 36.3% of the time during the postintervention period vs 25.3% and 25.0% among guidelines and peer comparison surgeons, respectively (<xref rid="ald240040f2" ref-type="fig">Figure 2</xref>). After adjusting for baseline above-guideline prescribing, peer comparison feedback significantly decreased guideline-discordant prescribing by 12.1 (95% CI, &#x02212;18.8 to &#x02212;5.5) percentage points (<italic>P</italic>&#x02009;=&#x02009;.001), and the guideline intervention significantly decreased guideline-discordant prescribing by 9.9 (95% CI, &#x02212;17.9 to &#x02212;1.9) percentage points (<italic>P</italic>&#x02009;=&#x02009;.02) in the postintervention period. The difference between intervention groups was not significant. Effect sizes were similar in each study month and remained significant 12 months post intervention.</p></sec><sec id="H1-4-ALD240040"><title>Discussion</title><p>This study shows that above-guideline prescribing of postsurgical opioids remained reduced 1 year after ceasing social norms&#x02013;based feedback. Effect sizes in the postintervention period were nearly identical to those estimated with the same models during the intervention period,<sup><xref rid="ald240040r3" ref-type="bibr">3</xref></sup> indicating sustained changes in prescribing behavior that remained integrated with surgery team practices. Reports of persistent change resulting from prescribing interventions are inconsistent; however, similar interventions using peer comparison feedback to improve guideline-concordant antibiotic prescribing have shown sustained postintervention improvements.<sup><xref rid="ald240040r4" ref-type="bibr">4</xref>,<xref rid="ald240040r5" ref-type="bibr">5</xref></sup> Further research is needed to examine the mechanisms driving postintervention persistence. Possibilities include continuation of prescribing habits triggered by contextual clues, new prosocial identities as responsible prescribers, and ongoing discussions with peers reinforcing appropriate prescribing.<sup><xref rid="ald240040r6" ref-type="bibr">6</xref></sup></p><p>Additional study of these feedback mechanisms could also optimize their implementation at scale. For example, shortening the intervention duration to 6 months may improve cost-effectiveness if the same persistent effect can be demonstrated. Our study is limited by only 1 year of postintervention follow-up. The sustained impact observed should continue to be evaluated over longer periods.</p></sec></body><back><ref-list id="REF-ALD240040"><title>References</title><ref id="ald240040r1"><label>1</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Brummett</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Waljee</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>Goesling</surname>
<given-names>J</given-names></string-name>, <etal/></person-group>. <article-title>New persistent opioid use after minor and major surgical procedures in US adults</article-title>. <source>JAMA Surg</source>. <year>2017</year>;<volume>152</volume>(<issue>6</issue>):<elocation-id>e170504</elocation-id>. doi:<pub-id pub-id-type="doi">10.1001/jamasurg.2017.0504</pub-id><pub-id pub-id-type="pmid">28403427</pub-id>
</mixed-citation></ref><ref id="ald240040r2"><label>2</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Schirle</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Stone</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Morris</surname>
<given-names>MC</given-names></string-name>, <etal/></person-group>. <article-title>Leftover opioids following adult surgical procedures: a systematic review and meta-analysis</article-title>. <source>Syst Rev</source>. <year>2020</year>;<volume>9</volume>(<issue>1</issue>):<fpage>139</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13643-020-01393-8</pub-id>
<pub-id pub-id-type="pmid">32527307</pub-id>
</mixed-citation></ref><ref id="ald240040r3"><label>3</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Wagner</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Kirkegaard</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Mariano</surname>
<given-names>LT</given-names></string-name>, <etal/></person-group>. <article-title>Peer comparison or guideline-based feedback and postsurgery opioid prescriptions: a randomized clinical trial</article-title>. <source>JAMA Health Forum</source>. <year>2024</year>;<volume>5</volume>(<issue>3</issue>):<elocation-id>e240077</elocation-id>. doi:<pub-id pub-id-type="doi">10.1001/jamahealthforum.2024.0077</pub-id>
<pub-id pub-id-type="pmid">38488780</pub-id>
</mixed-citation></ref><ref id="ald240040r4"><label>4</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Frost</surname>
<given-names>HM</given-names></string-name>, <string-name><surname>Wittmer</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Keith</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Durfee</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Jenkins</surname>
<given-names>TC</given-names></string-name></person-group>. <article-title>Sustainability of interventions to increase guideline-concordant durations of antibiotic therapy for children with acute otitis media</article-title>. <source>J Pediatr</source>. <year>2023</year>;<volume>253</volume>:<fpage>292</fpage>-<lpage>296.e2</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jpeds.2022.09.004</pub-id>
<pub-id pub-id-type="pmid">36088995</pub-id>
</mixed-citation></ref><ref id="ald240040r5"><label>5</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Linder</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Meeker</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Fox</surname>
<given-names>CR</given-names></string-name>, <etal/></person-group>. <article-title>Effects of behavioral interventions on inappropriate antibiotic prescribing in primary care 12 months after stopping interventions</article-title>. <source>JAMA</source>. <year>2017</year>;<volume>318</volume>(<issue>14</issue>):<fpage>1391</fpage>-<lpage>1392</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2017.11152</pub-id>
<pub-id pub-id-type="pmid">29049577</pub-id>
</mixed-citation></ref><ref id="ald240040r6"><label>6</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Frey</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Rogers</surname>
<given-names>T</given-names></string-name></person-group>. <article-title>Persistence: how treatment effects persist after interventions stop</article-title>. <source>Policy Insights Behav Brain Sci</source>. <year>2014</year>;<volume>1</volume>(<issue>1</issue>):<fpage>172</fpage>-<lpage>179</lpage>. doi:<pub-id pub-id-type="doi">10.1177/2372732214550405</pub-id>
</mixed-citation></ref></ref-list><notes notes-type="supplementary-material" id="note-ALD240040-1"><supplementary-material id="note-ALD240040-1-s" position="float" content-type="local-data"><label>Supplement 1.</label><caption><p>
Trial Protocol
</p></caption><media xlink:href="jamahealthforum-e245279-s001.pdf"/></supplementary-material><supplementary-material position="float" content-type="local-data"><label>Supplement 2.</label><caption><p><bold>eMethods.</bold> Description of Statistical Approach</p><p>
eReferences
</p></caption><media xlink:href="jamahealthforum-e245279-s002.pdf"/></supplementary-material><supplementary-material position="float" content-type="local-data"><label>Supplement 3.</label><caption><p>
Data Sharing Statement
</p></caption><media xlink:href="jamahealthforum-e245279-s003.pdf"/></supplementary-material></notes></back></article><!--requester-ID ksnell-->